Clinical studies recruiting near Aventura

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Sylvester Comprehensive Cancer Center - Aventura · Pfizer · NCT05020236 A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Skin and Cancer Associates (SCA) and the Center for Cosmetic · Ipsen · NCT07435428 Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
NA · Site 34 · BioStem Technologies · NCT06811909 Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Ba
Phase 1/Phase 2 · Spine and Wellness Centers of America · Creative Medical Technology Holdings Inc · NCT06053242 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · Bioresearch Partner - Aventura · UroGen Pharma Ltd. · NCT06774131 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Mount Sinai Comprehensive Cancer Center at Aventura · NRG Oncology · NCT05946213 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · VIN-Julie Schwartzbard · Bristol-Myers Squibb · NCT06976216 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · VIN-Julie Schwartzbard · Eli Lilly and Company · NCT05986292 Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-
Phase 3 · UM Sylvester Comprehensive Cancer Center at Aventura · NRG Oncology · NCT06500481 A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Mount Sinai Comprehensive Cancer Center at Aventura · Canadian Cancer Trials Group · NCT06592924 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · Arthritis and Rheumatic Disease Specialties ( Site 0016) · Merck Sharp & Dohme LLC · NCT07133633 Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
NA · Center for Clinical and Cosmetic Research · The Center for Clinical and Cosmetic Research · NCT07041489 Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · Visionary Investigators Network · GAP Innovations, PBC · NCT06584357 Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metas
Phase 2 · UM Sylvester Comprehensive Cancer Center at Aventura · National Cancer Institute (NCI) · NCT03606967 A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Phase 1 · Translational Clinical Research LLC · Amgen · NCT07590193 RA-PRO PRAGMATIC TRIAL
Phase 3 · George Munoz MD, PC · University of Alabama at Birmingham · NCT04692493 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Mount Sinai Comprehensive Cancer Center at Aventura · NRG Oncology · NCT05327686 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Local Institution - 2648 · Bristol-Myers Squibb · NCT07011745 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · GenesisCare USA - Aventura FP · NRG Oncology · NCT04852887 A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Phase 1/Phase 2 · Center for Clinical and Cosmetic Research · MediWound Ltd · NCT05157763 Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Phase 3 · Center for Clinical and Cosmetic Research · Sun Pharmaceutical Industries, Inc. · NCT07144852 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Mount Sinai Comprehensive Cancer Center at Aventura · Alliance for Clinical Trials in Oncology · NCT05677490 Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumor
Phase 2 · UM Sylvester Comprehensive Cancer Center at Aventura · National Cancer Institute (NCI) · NCT04665739 Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers
NA · Humanity Clinical Research, Corp · LifeNet Health · NCT07116876 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Mount Sinai Comprehensive Cancer Center at Aventura · National Cancer Institute (NCI) · NCT06058377 A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Phase 2 · AARDS Research, Inc. · Boehringer Ingelheim · NCT07409181 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · UM Sylvester Comprehensive Cancer Center at Aventura · SWOG Cancer Research Network · NCT04511013 A Study of Buntanetap in Participants With PD
Phase 2/Phase 3 · First Choice Neurology - Aventura Neurologic Associates · Annovis Bio Inc. · NCT07284784 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Mount Sinai Comprehensive Cancer Center at Aventura · NRG Oncology · NCT05080673

Look up another city

Look up another condition